Krystal Biotech, Inc. financial data

Symbol
KRYS on Nasdaq
Location
Pittsburgh, PA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 987% % 12%
Quick Ratio 39% % 76%
Debt-to-equity 9.2% % -5.6%
Return On Equity 19% % 82%
Return On Assets 17% % 83%
Operating Margin 41% % 83%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29,232,189 shares 1.5%
Common Stock, Shares, Outstanding 29,192,000 shares 1.4%
Entity Public Float $3,500,000,000 USD -24%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 28,944,000 shares 1.2%
Weighted Average Number of Shares Outstanding, Diluted 29,951,000 shares 0.71%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $389,130,000 USD 34%
Research and Development Expense $58,045,000 USD 8.3%
Operating Income (Loss) $161,295,000 USD 145%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $189,471,000 USD 99%
Income Tax Expense (Benefit) $15,360,000 USD -348%
Net Income (Loss) Attributable to Parent $204,831,000 USD 130%
Earnings Per Share, Basic 7.08 USD/shares 127%
Earnings Per Share, Diluted 6.84 USD/shares 128%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $496,304,000 USD 44%
Cash, Cash Equivalents, and Short-term Investments $827,800,000 USD 39%
Accounts Receivable, after Allowance for Credit Loss, Current $127,425,000 USD 22%
Inventory, Net $40,475,000 USD 53%
Assets, Current $1,024,602,000 USD 38%
Deferred Income Tax Assets, Net $22,824,000 USD
Property, Plant and Equipment, Net $150,776,000 USD -2.8%
Operating Lease, Right-of-Use Asset $7,239,000 USD 15%
Other Assets, Noncurrent $287,000 USD 24%
Assets $1,333,794,000 USD 26%
Accounts Payable, Current $3,238,000 USD -35%
Liabilities, Current $102,942,000 USD 0.93%
Operating Lease, Liability, Noncurrent $7,568,000 USD 25%
Other Liabilities, Noncurrent $3,724,000 USD 162%
Liabilities $114,234,000 USD 4.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,136,000 USD
Retained Earnings (Accumulated Deficit) $24,163,000 USD
Stockholders' Equity Attributable to Parent $1,219,560,000 USD 29%
Liabilities and Equity $1,333,794,000 USD 26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $30,969,000 USD 95%
Net Cash Provided by (Used in) Financing Activities $12,466,000 USD -218%
Net Cash Provided by (Used in) Investing Activities $54,769,000 USD -111%
Common Stock, Shares Authorized 80,000,000 shares 0%
Common Stock, Shares, Issued 29,192,000 shares 1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $36,095,000 USD -5424%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $496,304,000 USD 44%
Deferred Tax Assets, Valuation Allowance $14,214,000 USD -79%
Deferred Tax Assets, Gross $52,518,000 USD -37%
Operating Lease, Liability $9,339,000 USD 29%
Depreciation $5,724,000 USD -4.1%
Payments to Acquire Property, Plant, and Equipment $6,204,000 USD 392%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $206,157,000 USD 133%
Lessee, Operating Lease, Liability, to be Paid $17,021,000 USD 16%
Property, Plant and Equipment, Gross $182,057,000 USD 2.8%
Operating Lease, Liability, Current $1,771,000 USD 46%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,919,000 USD 50%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,864,000 USD 46%
Operating Lease, Weighted Average Discount Rate, Percent 0.097 pure 2.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7,682,000 USD 4.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,954,000 USD 50%
Deferred Tax Assets, Operating Loss Carryforwards $13,245,000 USD -8.9%
Unrecognized Tax Benefits $10,049,000 USD 142%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,990,000 USD 50%
Additional Paid in Capital $1,194,261,000 USD 5.9%
Deferred Tax Assets, Net of Valuation Allowance $38,304,000 USD 155%